Warner-Lambert acquisition of French firm Jouveinal brings antidepressant igmacine, asthma drug butixocort.
Executive Summary
WARNER-LAMBERT PURCHASE OF JOUVEINAL BRINGS ANTIDEPRESSANT IGMACINE, which is in Phase II, to company's product line. The company also gains long-acting glucocorticoid butixocort, a potential asthma and rhinitis therapy that has finished Phase I studies, from the privately-held French company. Jouveinal produces ethical and OTC pharmaceuticals, fine chemicals and food flavorings.